Revolution Medicines competitors

Revolution Medicines Competitors include Keryx Biopharmaceuticals, NovaBay Pharmaceuticals, Chiasma and LGC Biosearch Technologies.
Add company...
Revolution Medicines
Revolution Medicines
REVOLUTION Medicines is redesigning evolution's products to treat serious diseases. The company discovers and develops new drugs by deploying our innovative product engine to reconfigure substances that are inherently rich with biological function as a result of natural selection.
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Chiasma
Chiasma
Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.
LGC Biosearch Technologies
LGC Biosearch Technologies
LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
Founding Date
Founding Date
2015
Founding Date
1998
Founding Date
2000
Founding Date
2001
Founding Date
1842
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Redwood City, US HQ
Locations
New York, US HQ
Boston, US
Locations
Emeryville, US HQ
Locations
Waltham, US HQ
Ness Ziona, IL
Locations
Teddington, GB HQ
Employees
Employees
74
Employees
N/A
Employees
21
Employees
16
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
26.9 m
Valuation ($)
95.3 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
391
Twitter followers
2.2 k
Twitter followers
42
Twitter followers
2.4 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$60.6m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£131.2m (FY, 2018)
Net income
Net income
N/A
Net income
($163.4m) (FY, 2017)
Net income
N/A
Net income
($26.8m) (FY, 2017)
Net income
£9.2m (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 126m
Total funding raised
N/A
Total funding raised
$ 13.6m
Total funding raised
$ 139.8m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Keryx Biopharmaceuticals
HQ
New York, US

Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development of products for the treatment of renal diseases.

View company
NovaBay Pharmaceuticals
HQ
Emeryville, US
Employees
21

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

View company
Chiasma
HQ
Waltham, US
Employees
16

Chiasma is a biopharmaceutical company focused on improving the lives of patients who face challenges associated with existing treatments for their rare and serious chronic diseases.

View company
LGC Biosearch Technologies
HQ
Teddington, GB

LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.

View company